Preterm birth is the #1 cause of newborn death in Ohio
The OPQC Progesterone Project's goal is to decrease premature births in Ohio before 32 weeks by 10%, by identifying women with increased risk early in pregnancy and starting treatment with progesterone. In the first 3 years (2014-2017), the project has reduced repeated early preterm births before 32 weeks by 20%, and all Ohio births before 32 weeks by 6.6%. These pre-32 week births account for more than half of infant mortality in Ohio.
Progesterone is an evidence-based therapy shown to reduce preterm birth by more than 30% in women with prior preterm birth and/or short cervix through identification and treatment of appropriate candidates with progesterone prophylaxis.
OPQC is currently testing strategies for implementing this intervention with 23 Obstetrics outpatient clinics that were identified by OPQC’s 20 Charter OB sites. Successful strategies will then be disseminated to the other OB practices in Ohio.
The OPQC Progesterone Project is funded by the Ohio Department of Health and the Medicaid Technical Assistance and Policy Program (MEDTAPP), and administered by The Ohio Colleges of Medicine Government Resource Center. The views expressed in this presentation are solely those of the authors and do not represent the views of state or federal Medicaid programs. This study includes data provided by the Ohio Department of Health which should not be considered an endorsement of this study or its conclusions.